ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Home PRESS RELEASE Acerus Provides Business Update on NATESTO®
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 165187" data-attributes="member: 13851"><p><strong>Study shows patients have a positive perception of testosterone nasal gel </strong></p><p></p><p></p><p><span style="color: rgb(184, 49, 47)">Urologists and patients may have preconceived notions when it comes to acceptance and usability of various replacement testosterone therapies (TTh). We make assumptions that men will prefer a needle over a patch or a topical gel over a nasal gel. When Natesto® testosterone nasal gel (TNG) was introduced in Canada, we all weren’t too sure how it would be accepted. <strong>We presumed that nasal administration and twice daily (bid) to three times daily (tid) dosing would either be a big deal, leading to resistance by patients or no big deal, leading to widespread adoption.</strong></span> The truth is, beyond anecdote, we haven’t really examined patient preference of TNG vs. topical TTh. <strong><span style="color: rgb(184, 49, 47)">The My-T study </span></strong><span style="color: rgb(184, 49, 47)">in this month’s issue of CUAJ sheds some light on this subject in both novice and experienced users of replacement TTh. </span></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">What is interesting in this study is that patients, the majority of whom were prior testosterone users (experienced), perceived TNG to be more effective and convenient despite the more frequent dosing schedule than the available alternatives.</span></strong> <span style="color: rgb(184, 49, 47)">Patient compliance to treatment is an issue that plagues clinical care. The concern that bid or tid dosing will lead to patient dissatisfaction was not demonstrated in this study. <strong>In fact, this study sheds positive light on TNG from the practical viewpoint of the patient.</strong></span> It would be interesting to see if this translates into a change in prescribing patterns by both urologists and primary care providers at large.</p></blockquote><p></p>
[QUOTE="madman, post: 165187, member: 13851"] [B]Study shows patients have a positive perception of testosterone nasal gel [/B] [COLOR=rgb(184, 49, 47)]Urologists and patients may have preconceived notions when it comes to acceptance and usability of various replacement testosterone therapies (TTh). We make assumptions that men will prefer a needle over a patch or a topical gel over a nasal gel. When Natesto® testosterone nasal gel (TNG) was introduced in Canada, we all weren’t too sure how it would be accepted. [B]We presumed that nasal administration and twice daily (bid) to three times daily (tid) dosing would either be a big deal, leading to resistance by patients or no big deal, leading to widespread adoption.[/B][/COLOR] The truth is, beyond anecdote, we haven’t really examined patient preference of TNG vs. topical TTh. [B][COLOR=rgb(184, 49, 47)]The My-T study [/COLOR][/B][COLOR=rgb(184, 49, 47)]in this month’s issue of CUAJ sheds some light on this subject in both novice and experienced users of replacement TTh. [/COLOR] [B][COLOR=rgb(184, 49, 47)]What is interesting in this study is that patients, the majority of whom were prior testosterone users (experienced), perceived TNG to be more effective and convenient despite the more frequent dosing schedule than the available alternatives.[/COLOR][/B] [COLOR=rgb(184, 49, 47)]Patient compliance to treatment is an issue that plagues clinical care. The concern that bid or tid dosing will lead to patient dissatisfaction was not demonstrated in this study. [B]In fact, this study sheds positive light on TNG from the practical viewpoint of the patient.[/B][/COLOR] It would be interesting to see if this translates into a change in prescribing patterns by both urologists and primary care providers at large. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Home PRESS RELEASE Acerus Provides Business Update on NATESTO®
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top